Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy
Jordi G Barretina, Barry S. Taylor, Shantanu Otto Banerji et al. · Nature Genetics · 2010
Cited by 735 works. doi:10.1038/ng.619
Authors
- Jordi G Barretina
- Barry S. Taylor
- Shantanu Otto Banerji
- Alexis Ramos
- Mariana Lagos‐Quintana
- Penelope L. DeCarolis
- Kinjal Shah
- Nicholas D. Socci
- Barbara A. Weir
- Alan Loh Ho
- Derek Y. Chiang
- Boris A. Reva
- Craig H. Mermel
- Gad A. Getz
- Yevgenyi Antipin
- Rameen Beroukhim
- Charlie Hatton
- Richard Nicoletti
- Megan Hanna
References
- Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
- Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments
- Exploration, normalization, and summaries of high density oligonucleotide array probe level data
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- Cancer Statistics, 2009
- Consed: A Graphical Tool for Sequence Finishing
- Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors
- Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors
- Detection of large-scale variation in the human genome
- High Frequency of Mutations of the PIK3CA Gene in Human Cancers